Yidu Tech IPO Valuation: Attractive at the Low-End but Superior Growth Profile Justifies the Premium
The big data and AI solutions provider for healthcare sector in China, Yidu Tech has set the terms for its IPO and in this insight, we examine Yidu...
787 Views
Legend Biotech IPO: Pass on Valuation
Legend Biotech (LEGN US)Ā is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...
624 Views
ECM Weekly (24 May 2020) - NetEase and JD Homecoming, Legend Biotech, Nongfu Spring, Yeahka
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. The talk...
433 Views
Legend Biotech IPO Initiation: Choosing Therapies Ć La CAR-T
Legend Biotech (BLG US) is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...
385 Views
BBI Life: Scheme Doc Out, IFA Ekes Out A Fair Opinion
Back on the 20 January, BBI Life Sciences (1035 HK), the largest supplier of DNA synthesis products in the PRC, announced a privatisation OfferĀ by...
491 Views